Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 33 out of 100. Disease mechanisms

Topic: Brain proteins, microglia and lab models

Plain-language summary

PPA/3R had a mean age of 63.5 years (SD = 3.9), PPA/4R were 72.5 years (SD = 5.8), and controls were 63.4 years (SD = 6.8). In the left hemisphere, PPA/3R cases had smaller mean volumes than controls in the whole amygdala (p = 0.001) and all nuclei except the medial and paralaminar nuclei (i.e., lateral, basal, accessory basal, anterior amygdaloid area, cortical, central, and corticoamygdaloid transition area, all p <0.05). PPA/4R cases demonstrated smaller volumes than controls in only the paralaminar (p = 0.03) and corticoamygdaloid transition area (p = 0.009). Compared to PPA/4R, PPA/3R cases had reduced volumes in the whole amygdala (p = 0.04), lateral (p = 0.04), and cortical (p = 0.03) nuclei. There were no significant differences between disease groups in the right hemisphere. Results highlight the leftward asymmetry of disease in PPA and demonstrate increased atrophy of the amygdala in PPA/3R. Further, distinct portions of the amygdala were implicated in 3R versus 4R FTLD- tauopathy. Findings support prior research showing divergent neuropsychiatric phenotypes in FTLD-tauopathies, which may result from disruptions in amygdalar circuits governing emotional and behavioral processes. Future functional connectivity studies could offer greater insight into the pathways of limbic disruption in tauopathies.

What this study adds

Evidence grade: Low

This imaging study found that in primary progressive aphasia, cases with 3R tauopathy had more widespread left amygdala shrinkage than cases with 4R tauopathy. It maps patterns of atrophy only and does not test any treatment or prevention.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Stocks, J. K., Keszycki, R. M., Gutstein, D., Parrish, T., Castellani, R. J., Geula, C., et al. (2025). Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_100335

Vancouver

Stocks JK, Keszycki RM, Gutstein D, Parrish T, Castellani RJ, Geula C, et al. Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_100335. PMID: 41447155.

BibTeX

@article{stocks2025-41447155,
  author  = {Stocks, Jane K. and Keszycki, Rachel M. and Gutstein, Daniel and Parrish, Todd and Castellani, Rudolph J. and Geula, Changiz and Barbieri, Elena and Weıntraub, Sandra and others},
  title   = {{Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_100335},
  pmid    = {41447155},
  url     = {https://doi.org/10.1002/alz70856_100335}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This imaging study found that in primary progressive aphasia, cases with 3R tauopathy had more widespread left amygdala shrinkage than cases with 4R tauopathy. It maps patterns of atrophy only and does not test any treatment or prevention.

Study details

How this study scored 33/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 33 of 100.33 of 100 points earned67 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Tamar D. Gefen: h-index 25 (OpenAlex, whole career)
Institution's track record 2 / 3 Northwestern University: institution h-index 1,592 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41447155)
Free to read 2 / 2 Free to read
Total 33 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Disease mechanisms from nearby years

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Disease mechanisms

See all studies in Disease mechanisms →